INSIGHTS ON DRUG DEVELOPMENT
-
How To Reduce Batch Loss In Biopharma Production
Batch failures in biopharma remain costly despite improvements. Learn the leading causes in downstream purification and how supplier expertise can help reduce risk and protect production.
-
An All-In-One Solution For Residual DNA Quantitation
Explore an all-in-one solution for residual DNA quantitation with a 3D lab tour with virtual demos, videos, and interactive instrument guides to experience the full workflow.
-
An Alternative Method Of Drug-Excipient Characterization
Isothermal microcalorimetry (IMC) rapidly screens API-excipient compatibility, detecting physical and chemical interactions faster than conventional methods, saving time and effort in pharmaceutical formulation development.
-
LC-UV-Based Synthetic Peptide Impurity Tracking And Reporting
Explore a UPLC-UV method using Empower 3 Software to assess synthetic peptide purity. Learn how integrated tools streamline impurity tracking, data reporting, and compliance in peptide analysis workflows.
-
Assessing Reproductive Health With A Human Vagina-On-A-Chip4/17/2024
Learn about the development of a Vagina-on-a-Chip model designed to facilitate advanced research into bacterial vaginosis and other diseases from Gautam Mahajan, Ph.D., of Emulate.
-
Overcoming Food Effects, Variability, Solubility For A Non-Opioid Analgesic With Lipid-Based Formulations3/20/2026
Develop optimized lipid-based formulations to overcome solubility, stability, and food-effect challenges, enabling high-dose oral delivery and rapid progression to Phase 1 trials.
-
Accelerating The Study Of Viral Infection And Therapeutics8/7/2024
Explore the utilization of the Organ-Chips for investigating viral infections and expediting the development of new therapeutics.
-
Understand Fluorescence And How It Enhances Scientific Exploration9/24/2024
Deepen your understanding of fluorescence for research, and gain valuable insight into how to select appropriate fluorophores and fluorescent proteins for your experiments.
-
Automating High-Throughput Screens Using Patient-Derived Organoids3/17/2025
Many oncology drugs fail in later development stages due to inadequate predictive models. Explore how 3D cell models, like patient-derived organoids, offer a promising solution in the drug development process.
DRUG DEVELOPMENT SOLUTIONS
-
From safety considerations to kid-friendly dosing, we can help you get your pediatric formulation right.
-
Optimize your cell line strategy for better viral vector production.
-
Measure heat flow, weight loss, dimension change, or mechanical properties as a function of temperature.
-
Improve precision in ADME and Toxicology applications with a low-drug-absorption profile.
-
See how flexible synthesis platforms, structured CMC strategies, and advanced purification tools boost scalability, control impurities, and strengthen readiness for clinical and commercial oligo programs.